Preclinical Evaluation of ON203, A Novel Bioengineered mAb Targeting Oxidized Macrophage Migration Inhibitory Factor as an Anticancer Therapeutic

Gregor Rossmueller, Alexander Schinagl|Molecular Cancer Therapeutics|2023

Cited by 17